Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.

Vogel, M; Lichterfeld, M; Kaufmann, D E; Mui, S K; Altfeld, M; Voigt, E; Ahlenstiel, G; Kupfer, B; Walker, B; Spengler, U; Rockstroh, J K

Vogel, M; Lichterfeld, M; Kaufmann, D E; Mui, S K; Altfeld, M; Voigt, E; Ahlenstiel, G; Kupfer, B; Walker, B; Spengler, U; Rockstroh, J K.

Affiliation

Vogel M; Department of Internal Medicine I University of Bonn, Germany.

Eur J Med Res ; 11(7): 273-8, 2006 Jul 31.

Article in En | MEDLINE | ID: mdl-16899420

Subject(s)

Anti-HIV Agents/therapeutic use; HIV Seropositivity/drug therapy; HIV-1/genetics; RNA, Viral/genetics; Acute Disease; Adult; Antiretroviral Therapy, Highly Active/methods; CD4-Positive T-Lymphocytes/immunology; CD8-Positive T-Lymphocytes/immunology; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seropositivity/immunology; HIV Seropositivity/virology; Histocompatibility Testing; Humans; Lamivudine/therapeutic use; Lopinavir; Male; Pyrimidinones/therapeutic use; Retrospective Studies; Stavudine/therapeutic use; Treatment Outcome; Zidovudine/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / HIV-1 / HIV Seropositivity / Anti-HIV Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Eur J Med Res Journal subject: MEDICINA Year: 2006 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links